EXPERIENCES

COVID-19 Experience

NO. YEAR PHASE STUDY TYPE INDICATION
1 2022 Pilot study Local COVID-19 Treatment
2 2022 I/IIa Local COVID-19 Vaccine
3 2022 III Local COVID-19 Treatment
4 2022 III Global COVID-19 Treatment
5 2021 III Local COVID-19 Treatment
6 2021 Consulting Local COVID-19 Treatment
7 2021 II Local COVID-19 Treatment
8 2021 Consulting Local COVID-19 Treatment
9 2021 II Local COVID-19 Treatment
10 2021 II/III Local COVID-19 Treatment
11 2021 III Global COVID-19 Vaccine
12 2021 Consulting Global COVID-19 Vaccine
13 2021 I/IIa Local COVID-19 Vaccine
14 2021 II/III Global COVID-19 Treatment
15 2021 II Local COVID-19 Treatment
16 2021 I/II Local COVID-19 Treatment
17 2021 II Local COVID-19 Treatment
18 2021 III Local COVID-19 Treatment
19 2021 I/IIa Local COVID-19 Vaccine
20 2021 II Local COVID-19 Treatment
21 2020 I/II Local COVID-19 Vaccine
22 2020 I Local COVID-19 Treatment
23 2020 III Global COVID-19 Vaccine
24 2020 II Local COVID-19 Treatment
25 2020 II Global COVID-19 Treatment
26 2020 II Local COVID-19 Treatment
27 2020 II Local COVID-19 Treatment
28 2020 II Local COVID-19 Treatment
29 2020 I/IIa Local COVID-19 Vaccine
30 2020 I/IIa Local COVID-19 Vaccine
31 2020 Medical Device Local COVID-19 Diagnostic Kit
32 2020 I/IIa Local COVID-19 Treatment
[As of 2022.06.30]
Treatment Vaccine Diagnostic Kit 2520151050

* To overcome the COVID-19 pandemic, LSK Global PS has conducted 22 treatment studies (Global 3, Local 19), 9 vaccine studies (Global 3, Local 6), and 1 diagnostic kit study. (As of June 30th 2022)